FDA Clearance Tracker · P980035-S483
Adapta, Versa, Sensia IPGEnPulse E1 IPG Kappa DR (Kappa 700/600)
Last checked: Nov 20, 2026Latest source record: Jun 9, 2017 (this decision)Source: openFDAMethods & limitations
Decided
Jun 9, 2017
Approved
Time to decision
205 days
Received Nov 16, 2016. Calendar days, including time FDA spent waiting on the applicant.
Pathway
PMA supplement
Normal 180 Day Track
Device class
Class III
The decision
- FDA number
- P980035-S483
- Device name
- Adapta, Versa, Sensia IPGEnPulse E1 IPG Kappa DR (Kappa 700/600)
- Applicant
- Medtronic, Inc.
- Applicant location
- Mounds View, MN
- Received
- Nov 16, 2016
- Decided
- Jun 9, 2017
- Decision
- Approved
- Supplement type
- Normal 180 Day Track
- Reason for supplement
- Change Design/Components/Specifications/Material
- Original approval
- P980035
Device type
- Device class
- Class III
- Specialty
- CardiologyElectrophysiology
FDA's approval statement
As written in FDA's record.
Approval for hardware, firmware, labeling, and manufacturing changes to support replacing the Bluetooth (BT) Classic module with a BT Low Energy module in the monitor base station.
Source documents
Other decisions for Medtronic, Inc.
Matched on the applicant name as FDA recorded it. A company that files under several names will have more.
K263596 · Decided Oct 29, 2026 · 29 days after receipt
Device type: Catheter, Cannula And Tubing, Vascular, Cardiopulmonary Bypass (DWF) · Cardiology
7 more FDA decisions with a free account
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.